Importantly, relapsing ovarian cancer cells, that are usually chemoresistant displayed a clear sensitivity to apoptotic triggering by LBW242+TRAIL addition as well as primary ovarian cancer samples. This evidence concerns the gene TNFSF10 and ovarian carcinoma.